ReachMD

Be part of the knowledge.™

Project Oncology®

Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.

Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.

215

LikeLikedUnlike

Episodes 31-45 of 117

- Terry P. Mamounas, MD
  Peer
0
Project Oncology®
What the Evidence Supports: Insights on Axillary Management from SABCS 2021
What the Evidence Supports: Insights on Axillary Management from SABCS 2021
- Steven J. Chmura, MD, PhD
  Peer
0
Project Oncology®
The Promise & Reality of Oligometastatic Ablation: Updates in Breast Cancer from SABCS 2021
The Promise & Reality of Oligometastatic Ablation: Updates in Breast Cancer from SABCS 2021
- Timothy Yap, MBBS, PhD, FRCP
  Peer
0
Project Oncology®
Targeting the DNA Damage Response: Updates from the 2021 SABCS
Targeting the DNA Damage Response: Updates from the 2021 SABCS
- Timothy Yap, MBBS, PhD, FRCP
  Peer
0
Project Oncology®
Investigating the Next Generation of CDK2/4/6 Inhibitors: Insights from the 2021 SABCS
Investigating the Next Generation of CDK2/4/6 Inhibitors: Insights from the 2021 SABCS
- Jacob Sands, MD
  Peer
- Millie Das, MD
  Peer
1
Project Oncology®
Focusing on the Treatment Experience & Shared Decision-Making in HER2m NSCLC
Focusing on the Treatment Experience & Shared Decision-Making in HER2m NSCLC
- Jacob Sands, MD
  Peer
- Suneeta Senapati, MD, MSCE
  Peer
- Mindy Christianson, MD
  Peer
0
Project Oncology®
A Look at the Emerging Field of Oncofertility
A Look at the Emerging Field of Oncofertility
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Andrew H. Lipsky, MD
  Peer
0
Project Oncology®
Exploring the Mechanisms of Resistance to Targeted Therapies in CLL & MCL
Exploring the Mechanisms of Resistance to Targeted Therapies in CLL & MCL
- Daniel O. Persky, MD
  Peer
0
Project Oncology®
Anticipated Updates from ASH 2021: What’s New in CLL & MCL?
Anticipated Updates from ASH 2021: What’s New in CLL & MCL?
- Michael Wang, MD
  Peer
0
Project Oncology®
Exploring Expert Perspectives on MCL from the ASH Floors
Exploring Expert Perspectives on MCL from the ASH Floors
- Jacob Sands, MD
  Peer
- Tejas Patil, MD
  Peer
0
Project Oncology®
Evaluating NGS Testing in HER2m NSCLC: Overcoming Barriers to Clinical Adoption
Evaluating NGS Testing in HER2m NSCLC: Overcoming Barriers to Clinical Adoption
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Thomas Kipps, MD, PhD
  Peer
0
Project Oncology®
CLL & MCL Patient Management Strategies: A Review of the NCCN Guidelines
CLL & MCL Patient Management Strategies: A Review of the NCCN Guidelines
- John C. Byrd, MD
  Peer
0
Project Oncology®
Exploring the Clinical Value of IGHV & TP53 Sequencing for CLL
Exploring the Clinical Value of IGHV & TP53 Sequencing for CLL
- Jacob Sands, MD
  Peer
- Nicole Lamanna, MD
  Peer
0
Project Oncology®
Tailoring CLL Treatment Strategies & Improving Outcomes
Tailoring CLL Treatment Strategies & Improving Outcomes
- Thomas Kipps, MD, PhD
  Peer
0
Project Oncology®
Managing MCL Amid the Pandemic: Key Challenges & Treatment Considerations
Managing MCL Amid the Pandemic: Key Challenges & Treatment Considerations
- Lindsey Roeker, MD
  Peer
0
Project Oncology®
Expert Perspectives on CLL: Anticipated Highlights from the 63^rd Annual ASH Meeting
Expert Perspectives on CLL: Anticipated Highlights from the 63^rd Annual ASH Meeting

Segment Chapters

Playlist:

Recommended

Webpack App